Literature DB >> 22825627

Increased synovial expression of IL-27 by IL-17 in rheumatoid arthritis.

Seung Hoon Baek1, Seung Geun Lee, Young Eun Park, Geun Tae Kim, Chi Dae Kim, So Youn Park.   

Abstract

OBJECTIVES AND
DESIGN: Interleukin (IL) 17 plays an important role in synovial inflammation and bone destruction in rheumatoid arthritis (RA), while IL-27 exerts a regulatory role in T cell-mediated immune responses. Our aim was to study the influence of IL-17 on IL-27 production in RA.
MATERIALS AND METHODS: Following injection of IL-17 in the knee joint of CIA mice, synovium was examined for IL-17 and IL-27 expression by western blot, real-time PCR, and immunohistochemistry. IL-17 and IL-27 levels were measured by ELISA in mouse bone marrow-derived dendritic cells (BM-DCs) and in synovial fluid (SF) macrophages from RA patients.
RESULTS: IL-17 exacerbated disease progression in CIA mice. Histological analysis showed increased pannus formation associated with cartilage and bone erosion following injection with IL-17. The expression of IL-27 was increased in CIA mice. The expression of IL-17 and IL-27 was increased more in IL-17-injected CIA mice than in control mice. The majority of cells expressing IL-27 were co-localized with synovial macrophages. Increased expression of IL-27 by application of recombinant IL-17 was confirmed in CIA BM-DCs and in SF macrophages from RA patients.
CONCLUSION: IL-17 enhanced expression of IL-27 in synovial macrophages from RA patients and CIA mice, indicating an interaction between IL-17 and IL-27 as an autoregulatory mechanism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22825627     DOI: 10.1007/s00011-012-0534-7

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  20 in total

1.  WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27.

Authors:  Stefan Pflanz; Linda Hibbert; Jeanine Mattson; Rency Rosales; Elena Vaisberg; J Fernando Bazan; Joseph H Phillips; Terrill K McClanahan; Rene de Waal Malefyt; Robert A Kastelein
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

2.  Suppression of ongoing adjuvant-induced arthritis by neutralizing the function of the p28 subunit of IL-27.

Authors:  Ruth Goldberg; Gizi Wildbaum; Yaniv Zohar; Gila Maor; Nathan Karin
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

3.  IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages.

Authors:  D V Jovanovic; J A Di Battista; J Martel-Pelletier; F C Jolicoeur; Y He; M Zhang; F Mineau; J P Pelletier
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

Review 4.  Mechanisms of disease: the molecular and cellular basis of joint destruction in rheumatoid arthritis.

Authors:  Ulf Müller-Ladner; Thomas Pap; Renate E Gay; Michel Neidhart; Steffen Gay
Journal:  Nat Clin Pract Rheumatol       Date:  2005-12

5.  Local expression of interleukin-27 ameliorates collagen-induced arthritis.

Authors:  Sarah R Pickens; Nathan D Chamberlain; Michael V Volin; Arthur M Mandelin; Hemant Agrawal; Masanori Matsui; Takayuki Yoshimoto; Shiva Shahrara
Journal:  Arthritis Rheum       Date:  2011-08

6.  IL-27-producing CD14(+) cells infiltrate inflamed joints of rheumatoid arthritis and regulate inflammation and chemotactic migration.

Authors:  Shimei Tanida; Hiroyuki Yoshitomi; Masahiro Ishikawa; Takashi Kasahara; Koichi Murata; Hideyuki Shibuya; Hiromu Ito; Takashi Nakamura
Journal:  Cytokine       Date:  2011-05-17       Impact factor: 3.861

7.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells.

Authors:  Stefan Pflanz; Jackie C Timans; Jeanne Cheung; Rency Rosales; Holger Kanzler; Jonathan Gilbert; Linda Hibbert; Tatyana Churakova; Marilyn Travis; Elena Vaisberg; Wendy M Blumenschein; Jeanine D Mattson; Janet L Wagner; Wayne To; Sandra Zurawski; Terrill K McClanahan; Daniel M Gorman; J Fernando Bazan; Rene de Waal Malefyt; Donna Rennick; Robert A Kastelein
Journal:  Immunity       Date:  2002-06       Impact factor: 31.745

8.  Interleukin 17 (IL-17) increases the expression of Toll-like receptor-2, 4, and 9 by increasing IL-1beta and IL-6 production in autoimmune arthritis.

Authors:  Jun-Hee Lee; Mi-La Cho; Ju-In Kim; Young-Mee Moon; Hye-Jwa Oh; Geun-Tae Kim; Sun Ryu; Seung-Hoon Baek; Sun-Hee Lee; Ho-Youn Kim; Sung-Il Kim
Journal:  J Rheumatol       Date:  2009-02-17       Impact factor: 4.666

Review 9.  Regulation of immune responses by interleukin-27.

Authors:  Hiroki Yoshida; Yoshiyuki Miyazaki; Miyazaki Yoshiyuki
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

10.  Interleukin 27 attenuates collagen-induced arthritis.

Authors:  W Niedbala; B Cai; X Wei; A Patakas; B P Leung; I B McInnes; F Y Liew
Journal:  Ann Rheum Dis       Date:  2008-01-16       Impact factor: 19.103

View more
  5 in total

Review 1.  The emerging role of Interleukin 27 in inflammatory arthritis and bone destruction.

Authors:  Iannis E Adamopoulos; Stefan Pflanz
Journal:  Cytokine Growth Factor Rev       Date:  2012-11-16       Impact factor: 7.638

2.  Elevated serum level of IL-27 and VEGF in patients with ankylosing spondylitis and associate with disease activity.

Authors:  Tian-Tian Lin; Jing Lu; Chen-Yue Qi; Lin Yuan; Xiao-Lin Li; Li-Ping Xia; Hui Shen
Journal:  Clin Exp Med       Date:  2014-04-08       Impact factor: 3.984

3.  Increased IL-27/IL-27R expression in association with the immunopathology of murine ocular toxoplasmosis.

Authors:  Xinxin Tong; Shengjie Chen; Huanqin Zheng; Shiguang Huang; Fangli Lu
Journal:  Parasitol Res       Date:  2018-05-19       Impact factor: 2.289

Review 4.  Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.

Authors:  Etheresia Pretorius; Oore-Ofe Akeredolu; Prashilla Soma; Douglas B Kell
Journal:  Exp Biol Med (Maywood)       Date:  2016-11-26

5.  Human interleukin-27: wide individual variation in plasma levels and complex inter-relationships with interleukin-17A.

Authors:  M A Forrester; L Robertson; N Bayoumi; B D Keavney; R N Barker; M A Vickers
Journal:  Clin Exp Immunol       Date:  2014-11       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.